Generated by DeepSeek V3.2| Diagnostic and Statistical Manual of Mental Disorders | |
|---|---|
![]() | |
| MeshID | D019959 |
Diagnostic and Statistical Manual of Mental Disorders. It is the primary classification system for mental disorders used by clinicians, researchers, and institutions in the United States and many other countries. Published by the American Psychiatric Association, it provides standardized criteria to facilitate reliable diagnosis, guide treatment, and structure research. Its development and revisions involve extensive committees of psychiatrists and other mental health professionals.
The first edition was published in 1952, influenced heavily by the statistical data collection needs of the United States Census Bureau and the United States Armed Forces after World War II. The development of the second edition in 1968 was marked by the influence of psychoanalytic theory, while the third edition in 1980, led by figures like Robert Spitzer, introduced a major paradigm shift toward descriptive, criterion-based diagnosis. This revision was partly a response to controversies like those surrounding homosexuality, which was removed as a disorder, and aimed to increase reliability for research purposes, aligning more with the International Classification of Diseases published by the World Health Organization.
The manual organizes disorders into diagnostic categories based on shared phenomenology. It utilizes a multi-axial system in some editions, but the current structure presents disorders in chapters such as "Neurodevelopmental Disorders," "Schizophrenia Spectrum and Other Psychotic Disorders," and "Depressive Disorders." Each disorder entry includes descriptive text, diagnostic criteria specifying required symptoms and duration, and information on prevalence, risk factors, and differential diagnosis. The system is designed for use across various settings, including private practice, hospitals like the Mayo Clinic, and research institutions such as the National Institute of Mental Health.
The manual has faced significant criticism from within and outside psychiatry. Critics, including the British Psychological Society and psychiatrists like Allen Frances, argue it medicalizes normal human experience, risks over-diagnosis, and is overly influenced by the pharmaceutical industry. Debates have surrounded specific diagnoses, such as the expansion of autism spectrum disorder criteria and the inclusion of disruptive mood dysregulation disorder. The National Institute of Mental Health launched the Research Domain Criteria project as an alternative, neuroscience-based framework, highlighting perceived limitations in the current diagnostic validity.
It is integral to clinical practice, forming the basis for treatment planning, communication between professionals, and eligibility for services. Its codes are required for insurance reimbursement in systems like Medicare and by managed care organizations. It guides clinical decision-making in diverse settings, from the Veterans Health Administration to community mental health centers, and informs the design of clinical trials funded by entities like the National Institutes of Health. Its use is taught in training programs for psychiatrists, psychologists, and clinical social workers across institutions like Harvard University.
Major editions include the first and second, the landmark third edition in 1980, and a revised third edition in 1987. The fourth edition was published in 1994, with a text revision in 2000. The fifth and current edition was released in 2013 after a lengthy revision process involving field trials and public commentary. Updates are now intended to be incremental, with revisions like the one published in 2022, allowing for more timely incorporation of new research evidence without waiting for a new full edition.
Category:Medical classification Category:Psychiatry